SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shreaya Chakroborty, Grace E. Stutzmann, Calcium channelopathies and Alzheimer's disease: Insight into therapeutic success and failures, European Journal of Pharmacology, 2014, 739, 83

    CrossRef

  2. 2
    Y. Yabuki, Y. Ohizumi, A. Yokosuka, Y. Mimaki, K. Fukunaga, Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice, Neuroscience, 2014, 259, 126

    CrossRef

  3. 3
    Juan-Alberto Arranz-Tagarro, Cristóbal de los Ríos, Antonio G García, Juan-Fernando Padín, Recent patents on calcium channel blockers: emphasis on CNS diseases, Expert Opinion on Therapeutic Patents, 2014, 24, 9, 959

    CrossRef

  4. 4
    Juliane Proft, Norbert Weiss, T-type Ca2+ channels: New players in the aging brain, Communicative & Integrative Biology, 2014, 7, 1, e28424

    CrossRef

  5. 5
    Liang Chen, Yanyan Miao, Lin Chen, Jing Xu, Xinxing Wang, Han Zhao, Yi Shen, Yi Hu, Yunpeng Bian, Yuanyuan Shen, Jutao Chen, Yingying Zha, Long-Ping Wen, Ming Wang, The role of low levels of fullerene C60 nanocrystals on enhanced learning and memory of rats through persistent CaMKII activation, Biomaterials, 2014, 35, 34, 9269

    CrossRef

  6. 6
    Yoshimasa Yamaguchi, Kentaro Takeda, Masataka Hino, Combination Effects of ZSET1446/ST101 With Memantine on Cognitive Function and Extracellular Acetylcholine in the Hippocampus, Journal of Pharmacological Sciences, 2013, 123, 4, 347

    CrossRef

  7. 7
    Yui Yamamoto, Norifumi Shioda, Feng Han, Shigeki Moriguchi, Kohji Fukunaga, The Novel Cognitive Enhancer ST101 Enhances Acetylcholine Release in Mouse Dorsal Hippocampus Through T-type Voltage-Gated Calcium Channel Stimulation, Journal of Pharmacological Sciences, 2013, 121, 3, 212

    CrossRef